A Hybrid MPC-PID control system design for the continuous purification and processing of active pharmaceutical ingredients

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

In this work, a hybrid MPC (model predictive control)-PID (proportional-integral-derivative) control system has been designed for the continuous purification and processing framework of active pharmaceutical ingredients (APIs). The specific unit operations associated with the purification and processing of API have been developed from first-principles and connected in a continuous framework in the form of a flowsheet model. These integrated unit operations are highly interactive along with the presence of process delays. Therefore, a hybrid MPC-PID is a promising alternative to achieve the desired control loop performance as mandated by the regulatory authorities. The integrated flowsheet model has been simulated in gPROMSTM (Process System Enterprise, London, UK). This flowsheet model has been linearized in order to design the control scheme. The ability to track the set point and reject disturbances has been evaluated. A comparative study between the performance of the hybrid MPC-PID and a PID-only control scheme has been presented. The results show that an enhanced control loop performance can be obtained under the hybrid control scheme and demonstrate that such a scheme has high potential in improving the efficiency of pharmaceutical manufacturing operations.

Original languageEnglish (US)
Pages (from-to)392-418
Number of pages27
JournalProcesses
Volume2
Issue number2
DOIs
StatePublished - Jun 1 2014

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Chemical Engineering (miscellaneous)
  • Process Chemistry and Technology

Keywords

  • Continuous processing
  • Crystallization
  • MPC
  • PID
  • Pharmaceutical manufacturing
  • Powder mixing

Fingerprint

Dive into the research topics of 'A Hybrid MPC-PID control system design for the continuous purification and processing of active pharmaceutical ingredients'. Together they form a unique fingerprint.

Cite this